References
- Talley NJ, Silverstein MD, Agrues L et al AGA technical review: evaluation of dyspepsia. Gastroentemlogy 114,582–595 (1998).
- Bytzer P, Talley NJ. Dyspepsia. Ann. Intern. Med. 134,815–822 (2001).
- Agreus L. Natural history of dyspepsia. Gut 50\(Suppl. 4), 2–9 (2002).
- Jones R. Dyspeptic symptoms in the community. Gut 30,893–898 (1989).
- Knill-Jones RR Geographical differences in the prevalence of dyspepsia. Scant/. Gastmenterol 26\(Suppl. 182), 17–24 (1991).
- Nyren O, Lindberg G, Lindstrom E, Marke LA, Seensalu R. Economic costs of functional dyspepsia. PharmacoEconomics 1(5), 312–324 (1992).
- Agreus L, Borgquist L. The cost of gastroesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. PharmacoEconomics 20 (5), 347–355 (2002).
- Siskind V, Kelly JP, Kaufman DW. Estimating risks for matching factors in case-control studies. j Clin. Epidemiol 53(3), 251–256 (2002).
- Armitage P, Berry G. Statistica medica. In: Metodi Statistic] per la Ricerca in Medicina. McGraw-Hill, NY, USA (1996).
- Briggs A, Gray A. The distribution of healthcare costs and their statistical analysis for economic evaluation. Health. Serv. Res. Folic. 3(4), 233–245 (1998).
- Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. PharmacoEconomics 19(6), 609–621 (2001).
- •Provides an interesting overview of the role and criteria for budget impact analysis.
- Greenberg PE, Arcelus A, Birnbaum HG et al Pharmacoeconomics and health policy. Current applications and prospects for the future. PharmacoEconomics 16(5 pt 1), 425–432 (1999).
- Nuijten MJC. Pharamacoeconomics in European decision making. Value Health 2(5), 319–322 (1999).
- Drummond M, Dubois D, Garattini L et al Current trends in the use of pharmacoeconomics and outcome research in Europe. Value Health 2(5), 323–332 (1999).
- Relman AS. Relman AS. Assessment and accountability. The third revolution in medical care. N Engl. Med. 319 (18), 1220–1222 (1998).
- ••Provides an interesting overview ofhealthcare systems evolution over the last few years.
- Roper WL, Winkenwerder W, Hackbarth GM et al Effectiveness in healthcare. An initiative to evaluate and improve medical practice N Eng" I Med. 319, 1197–1202 (1998).
- ••Provides an interesting overview ofhealthcare systems evolution over the last few years.
- Wennberg JE. Outcome research, cost containment and the fear of healthcare rationing. BE Med. 1. 325 (1), 66–67 (1991).
- Epstein RS, Sherwood LM. From outcomes management to disease management: a guide for the perplexed. Ann. Intern. Med. 124(9), 832–837 (1996).
- ••Provides an interesting overview of the step-by-step process from outcomes research to disease management.